Skip to main content

Constrictive Pericarditis vs Restrictive Cardiomyopathy

 

Constrictive Pericarditis vs Restrictive Cardiomyopathy
Constrictive Pericarditis vs Restrictive Cardiomyopathy


A Practical, Clinically Oriented Comparison


Constrictive pericarditis (CP) and restrictive cardiomyopathy (RCM) present with remarkably similar clinical features—predominantly right-sided heart failure with preserved or near-preserved systolic function. Despite this overlap, the underlying pathology, diagnostic clues, and management strategies differ fundamentally. Accurate distinction is critical because constrictive pericarditis is potentially curable, while restrictive cardiomyopathy usually requires long-term medical therapy or advanced heart failure interventions.



---


Pathophysiologic Basis


Constrictive pericarditis is caused by a rigid, often thickened or calcified pericardium that limits diastolic expansion of the heart. Ventricular filling becomes abruptly halted in mid-diastole, leading to exaggerated ventricular interdependence and marked respiratory variation in intracardiac flows.


Restrictive cardiomyopathy, in contrast, is a myocardial disease. The ventricles are stiff due to infiltration (e.g., amyloidosis), fibrosis, or hypertrophy, resulting in impaired diastolic relaxation without an external constraint. Ventricular interdependence is minimal, and respiratory variation is blunted.



---


Clinical Examination


In constrictive pericarditis, classic physical findings include:


Positive Kussmaul sign (rise or lack of fall in JVP with inspiration)


Absent or poorly palpable apical impulse


Early diastolic pericardial knock due to abrupt cessation of ventricular filling



In restrictive cardiomyopathy:


Kussmaul sign may be present or absent


PMI is often forceful


Third and fourth heart sounds may be heard


Systolic murmurs of mitral or tricuspid regurgitation are more common due to annular dilation




---


Electrocardiographic Features


Constrictive pericarditis


Low QRS voltage may be seen


ECG is often otherwise unremarkable



Restrictive cardiomyopathy


Low voltage is typical in infiltrative forms, especially amyloidosis


Conduction abnormalities, atrial arrhythmias, and AV block are more frequent




---


Echocardiographic Hallmarks


Echocardiography is central to differentiation.


Respiratory Variation


CP: Marked respirophasic variation (25–40%) in trans-valvular Doppler flows


Inspiration increases tricuspid inflow and decreases mitral inflow



RCM: <10% respiratory variation



Tissue Doppler Imaging


CP: Preserved or increased medial mitral annular e′ velocity (>12 cm/s), reflecting normal myocardial relaxation (“annulus paradoxus”)


RCM: Reduced e′ velocity (<8 cm/s), indicating intrinsic myocardial dysfunction



Additional Echocardiographic Clues


CP


Septal bounce in early diastole


Expiratory hepatic vein diastolic flow reversal


Normal ventricular wall thickness



RCM


Biatrial enlargement (a key feature)


Inspiratory hepatic vein flow reversal


Increased ventricular wall thickness in infiltrative diseases





---


CT and Cardiac MRI


Constrictive pericarditis


Thickened or calcified pericardium


Pericardial enhancement on MRI may suggest active inflammation



Restrictive cardiomyopathy


Normal pericardium


Myocardial late gadolinium enhancement patterns help identify infiltrative or fibrotic etiologies




---


Biomarkers


CP: NT-proBNP levels are variable and often lower than expected for the degree of congestion


RCM: NT-proBNP is typically markedly elevated, reflecting myocardial involvement and high filling pressures




---


Hemodynamic Assessment on Cardiac Catheterization


Invasive hemodynamics remain the gold standard when noninvasive tests are inconclusive.


Shared Features


Elevated and near-equal diastolic pressures


Prominent x and y descents in atrial pressure tracings


Dip-and-plateau (square root) sign in ventricular pressure curves

(more pronounced in constriction)



Distinguishing Findings


Constrictive pericarditis


LVEDP ≈ RVEDP


RV systolic pressure usually <55 mmHg


Discordance of LV and RV systolic pressures with respiration

(LV pressure falls while RV pressure rises during inspiration)


Systolic area index >1.1 (highly specific)



Restrictive cardiomyopathy


LVEDP > RVEDP (especially with volume loading)


RV systolic pressure often ≥55 mmHg


Concordant LV and RV systolic pressure changes during respiration


Systolic area index ≤1.1




---


Endomyocardial Biopsy


Constrictive pericarditis: Usually normal myocardium


Restrictive cardiomyopathy: May reveal a specific etiology such as amyloid deposition, fibrosis, or storage disease




---


Therapeutic and Prognostic Implications


This distinction has major management consequences:


Constrictive pericarditis can be definitively treated with pericardiectomy, offering symptomatic relief and potential cure.


Restrictive cardiomyopathy is managed with diuretics, rate control, and treatment of the underlying cause; prognosis depends on etiology and disease progression.




---


Key Take-Home Points


Think pericardium in constrictive pericarditis and myocardium in restrictive cardiomyopathy.


Respiratory variation and preserved e′ velocity strongly favor constriction.


Biatrial enlargement, reduced e′ velocity, and markedly elevated NT-proBNP suggest restriction.


Cardiac catheterization remains the definitive test when uncertainty persists.


Correct diagnosis directly alters management and outcomes.




---


Understanding these nuances allows clinicians to confidently differentiate two clinically similar but fundamentally different diseases, ensuring timely and appropriate treatment.



Comments

Popular posts from this blog

STEMI ECG Criteria and Universal Definition of MI

  STEMI ECG Criteria and the Universal Definition of Myocardial Infarction: A Complete Guide for Clinicians Early and accurate diagnosis of acute myocardial infarction (AMI) remains the cornerstone of reducing morbidity and mortality in patients presenting with chest pain. Among all forms of acute coronary syndromes (ACS), ST-elevation myocardial infarction (STEMI) represents the most time-sensitive emergency, requiring immediate reperfusion therapy. This article provides a clinically relevant summary of the STEMI ECG criteria and the Universal Definition of Myocardial Infarction (UDMI), based on the latest consensus guidelines from the ESC, ACC, AHA, and WHF. --- 1. Understanding STEMI: Why Accurate ECG Interpretation Matters A 12-lead ECG remains the first and most critical diagnostic test when evaluating suspected myocardial infarction. STEMI is identified when there is evidence of acute coronary artery occlusion, producing transmural ischemia and characteristic ST-segment eleva...

2025 AHA/ACC Hypertension Guidelines Key points

  2025 AHA/ACC Hypertension Guidelines Explained: A Clear Summary for Clinicians and Students Hypertension remains one of the most significant contributors to cardiovascular morbidity and mortality worldwide. With continual refinement of evidence and risk-based strategies, the 2025 AHA/ACC Hypertension Guidelines bring an updated, practical approach that clinicians can use in daily practice. To make learning easier, I’ve created a clean and modern infographic summarizing all major recommendations. You can download it below and use it for study, teaching, or clinical reference. Download Infographic (PNG): 2025 Hypertension Guideline Infographic This post breaks down the key points from the guidelines and complements the infographic for a complete understanding. --- BP Categories: Understanding the Updated Thresholds The guidelines maintain the well-established classification of blood pressure: Normal: <120 / <80 Elevated: 120–129 / <80 Stage 1 Hypertension: 130–139 and/or 8...

π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š

 π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.